A Study to Test 2 Doses of the HRV Vaccine Given With or Without OPV in Healthy Infants in Bangladesh

Update Il y a 4 ans
Reference: NCT00139334

Woman and Man

  • | Country :
  • Bangladesh
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The main objective of this study is to provide immunogenicity data for GSK Biologicals' HRV vaccine when co-administered with OPV or when given alone (HRV vaccine dose given 15 days after the OPV dose).


Inclusion criteria

  • Infections, Rotavirus

Links